Semperit: Just under EUR 50 million impairment loss at Sempermed – annual result negative

The Executive Board of the Semperit AG Holding today quantified the impairment loss in the Medical Sector (Sempermed segment) at just under EUR 50 million. The earnings after taxes for Q1-3 2019 are expected to be around EUR –35 million; the annual result will be negative as well.

As announced in the ad-hoc release on November 13, 2019, the publication of the interim Group report as of September 30, 2019 was postponed. The publication date was now set for December 19, 2019.